Kai Blin
Impact in
- Pharmacology top 0.02%
- Microbial Natural Products and Biosynthesis
- Biotechnology top 0.05%
- Marine Sponges and Natural Products
Papers in
- Pharmacology 42
- Microbial Natural Products and Biosynthesis 42
-
- Genomics and Phylogenetic Studies 23
- Plant biochemistry and biosynthesis 15
- Microbial Metabolic Engineering and Bioproduction 10
- RNA and protein synthesis mechanisms 8
- CRISPR and Genetic Engineering 7
- Metabolomics and Mass Spectrometry Studies 5
- Co-authors
- Tilmann Weber (40 shared papers)Marnix H. Medema (19 shared papers)Simon J. Shaw (9 shared papers)Sang Yup Lee (12 shared papers)Rainer Breitling (4 shared papers)Eriko Takano (4 shared papers)Michael Andrew Fischbach (3 shared papers)Gilles P. van Wezel (2 shared papers)
- Journals
- Nucleic Acids Research (27 papers)Synthetic and Systems Biotechnology (4 papers)ACS Chemical Biology (2 papers)PLoS ONE (2 papers)Briefings in Bioinformatics (2 papers)
- Partner nations
- DenmarkGermanyNetherlands
In The Last Decade
Kai Blin
53 papers receiving 15.5k citations
Kai Blin's Hit Papers
Peers
Comparison fields: 5 of 142
- Pharmacology 7.3k
- Biotechnology 2.6k
- Microbiology 158
- Molecular Biology 10.0k
- Ecology 2.2k
Countries citing papers authored by Kai Blin
This map shows the geographic impact of Kai Blin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Blin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Blin more than expected).
Fields of papers citing papers by Kai Blin
This network shows the impact of papers produced by Kai Blin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Blin. The network helps show where Kai Blin may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Blin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline Hit paper breakdown → | 2019 | 2298 |
| 2 | antiSMASH 6.0: improving cluster detection and comparison capabilities Hit paper breakdown → | 2021 | 1945 |
| 3 | antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences Hit paper breakdown → | 2011 | 1613 |
| 4 | antiSMASH 3.0—a comprehensive resource for the genome mining of biosynthetic gene clusters Hit paper breakdown → | 2015 | 1573 |
| 5 | antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation Hit paper breakdown → | 2023 | 1467 |
| 6 | antiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identification Hit paper breakdown → | 2017 | 980 |
| 7 | Minimum Information about a Biosynthetic Gene cluster Hit paper breakdown → | 2015 | 695 |
| 8 | antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producers Hit paper breakdown → | 2013 | 689 |
| 9 | NRPSpredictor2—a web server for predicting NRPS adenylation domain specificity Hit paper breakdown → | 2011 | 528 |
| 10 | MIBiG 2.0: a repository for biosynthetic gene clusters of known function Hit paper breakdown → | 2019 | 445 |
| 11 | 2017 | 347 | |
| 12 | MIBiG 3.0: a community-driven effort to annotate experimentally validated biosynthetic gene clusters Hit paper breakdown → | 2022 | 292 |
| 13 | Artificial intelligence for natural product drug discovery Hit paper breakdown → | 2023 | 288 |
| 14 | 2017 | 250 | |
| 15 | 2016 | 202 | |
| 16 | antiSMASH 8.0: extended gene cluster detection capabilities and analyses of chemistry, enzymology, and regulation Hit paper breakdown → | 2025 | 197 |
| 17 | 2020 | 168 | |
| 18 | 2019 | 165 | |
| 19 | 2018 | 158 | |
| 20 | 2017 | 150 |
About Kai Blin
Kai Blin is a scholar working on Pharmacology, Molecular Biology, Biotechnology, Computational Theory and Mathematics and Molecular Medicine, having authored 57 papers that have together received 15.8k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (42 papers), Genomics and Phylogenetic Studies (23 papers), Plant biochemistry and biosynthesis (15 papers), Microbial Metabolic Engineering and Bioproduction (10 papers), RNA and protein synthesis mechanisms (8 papers), CRISPR and Genetic Engineering (7 papers), Computational Drug Discovery Methods (7 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Pharmacology (7.3k citations), Biotechnology (2.6k citations), Microbiology (158 citations), Molecular Biology (10.0k citations) and Ecology (2.2k citations). Kai Blin has collaborated with scholars based in Denmark, Germany and Netherlands. Frequent co-authors include Tilmann Weber, Marnix H. Medema, Simon J. Shaw, Sang Yup Lee, Rainer Breitling, Eriko Takano, Michael Andrew Fischbach, Gilles P. van Wezel, Nadine Ziemert and Kat Steinke. Their work appears in journals such as Nucleic Acids Research, Synthetic and Systems Biotechnology, ACS Chemical Biology, PLoS ONE and Briefings in Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.